Back to top

rsi: Archive

Zacks Equity Research

Here's Why PLAYSTUDIOS, Inc. (MYPS) is Poised for a Turnaround After Losing -18.12% in 4 Weeks

PLAYSTUDIOS, Inc. (MYPS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

MYPSPositive Net Change

Zacks Equity Research

Tellurian Inc. (TELL) Loses -51.79% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Tellurian Inc. (TELL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

TELLPositive Net Change

Zacks Equity Research

Down -41.9% in 4 Weeks, Here's Why Confluent (CFLT) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Confluent (CFLT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CFLTNegative Net Change

Zacks Equity Research

Procore Technologies (PCOR) Loses -26.01% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Procore Technologies (PCOR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

PCORNegative Net Change

Zacks Equity Research

Down -28.48% in 4 Weeks, Here's Why Paylocity (PCTY) Looks Ripe for a Turnaround

Paylocity (PCTY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

PCTYNegative Net Change

Zacks Equity Research

InflaRx N.V. (IFRX) Loses -47.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

InflaRx N.V. (IFRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

IFRXNegative Net Change

Zacks Equity Research

Down -15.37% in 4 Weeks, Here's Why CRA (CRAI) Looks Ripe for a Turnaround

CRA (CRAI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

CRAIPositive Net Change

Zacks Equity Research

Inari Medical, Inc. (NARI) Loses -27.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Inari Medical, Inc. (NARI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

Down -13.28% in 4 Weeks, Here's Why You Should You Buy the Dip in KBR (KBR)

KBR (KBR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

KBRPositive Net Change

Zacks Equity Research

Down -14.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Criteo S.A. (CRTO)

Criteo S.A. (CRTO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CRTOPositive Net Change

Zacks Equity Research

Down -8.48% in 4 Weeks, Here's Why You Should You Buy the Dip in HealthEquity (HQY)

HealthEquity (HQY) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

HQYPositive Net Change

Zacks Equity Research

Down -31.39% in 4 Weeks, Here's Why Accolade (ACCD) Looks Ripe for a Turnaround

Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

After Plunging -12.24% in 4 Weeks, Here's Why the Trend Might Reverse for TriNet (TNET)

TriNet (TNET) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

TNETPositive Net Change

Zacks Equity Research

Down -9.37% in 4 Weeks, Here's Why You Should You Buy the Dip in Clean Harbors (CLH)

The heavy selling pressure might have exhausted for Clean Harbors (CLH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CLHNo Net Change

Zacks Equity Research

Down -21.83% in 4 Weeks, Here's Why Trupanion (TRUP) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Trupanion (TRUP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

TRUPPositive Net Change

Zacks Equity Research

After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)

Outset Medical, Inc. (OM) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

OMPositive Net Change

Zacks Equity Research

After Plunging -5.91% in 4 Weeks, Here's Why the Trend Might Reverse for Honda (HMC)

Honda (HMC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

HMCNegative Net Change

Zacks Equity Research

Down -50.77% in 4 Weeks, Here's Why You Should You Buy the Dip in Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics, Inc. (ARQT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ARQTPositive Net Change

Zacks Equity Research

Seadrill (SDRL) Loses -10.06% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Seadrill (SDRL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SDRLNegative Net Change

Zacks Equity Research

Orla Mining Ltd. (ORLA) Loses -6.38% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Orla Mining Ltd. (ORLA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

ORLAPositive Net Change

Zacks Equity Research

After Plunging -18.86% in 4 Weeks, Here's Why the Trend Might Reverse for Kinsale Capital Group, Inc. (KNSL)

Kinsale Capital Group, Inc. (KNSL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

KNSLPositive Net Change

Zacks Equity Research

Patria Investments (PAX) Loses -10.73% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Patria Investments (PAX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PAXNegative Net Change

Zacks Equity Research

Emerson Electric (EMR) Loses -7.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Emerson Electric (EMR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

EMRPositive Net Change

Zacks Equity Research

Veeva (VEEV) Loses -5.42% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Veeva (VEEV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

VEEVPositive Net Change

Zacks Equity Research

Arcutis Biotherapeutics, Inc. (ARQT) Loses -51.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Arcutis Biotherapeutics, Inc. (ARQT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

ARQTPositive Net Change